Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Subscribe To Our Newsletter & Stay Updated
